These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 697893)

  • 1. Reversal of bretylium blockade of adrenergic nerve terminals by tetraethylammonium.
    Kirpekar M; Kirpekar SM; Prat JC
    Biochem Pharmacol; 1978 May; 27(10):1512-3. PubMed ID: 697893
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of guanethidine blockade of sympathetic nerve terminals by tetraethylammonium and 4-aminopyridine.
    Kirpekar M; Kirpekar SM; Prat JC
    Br J Pharmacol; 1978 Jan; 62(1):75-8. PubMed ID: 620099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of bretylium and acetylcholine at sympathetic nerve endings.
    Fischer JE; Weise VK; Kopin IJ
    J Pharmacol Exp Ther; 1966 Sep; 153(3):523-9. PubMed ID: 5921529
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of tetraethylammonium on noradrenaline release from cat spleen treated with tetrodotoxin.
    Kirpekar SM; Prat JC
    Nature; 1978 Dec; 276(5688):623-4. PubMed ID: 723946
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of phenoxybenzamine with guanethidine and bretylium at the sympathetic nerve endings of the isolated perfused spleen of the cat.
    Thoenen H; Huerlimann A; Haefely W
    J Pharmacol Exp Ther; 1966 Feb; 151(2):189-95. PubMed ID: 5932597
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation by tetraethylammonium of the response of the cat spleen to postganglionic sympathetic nerve stimulation.
    Thoenen H; Haefely W; Staehelin H
    J Pharmacol Exp Ther; 1967 Sep; 157(3):532-40. PubMed ID: 6048013
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of guanethidine, bretylium and debrisoquine on the accumulation of noradrenaline in constricted postganglionic sympathetic nerves in vitro.
    Tomlinson DR; Mayor D
    Eur J Pharmacol; 1973 Feb; 21(2):161-70. PubMed ID: 4696099
    [No Abstract]   [Full Text] [Related]  

  • 8. Positive chronotropic effect of vagus on sinus node.
    Holder MS; Anolik MA; Vassalle M
    Arch Sci Biol (Bologna); 1971; 55(2):103-18. PubMed ID: 5155637
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of drugs on adrenergic nerve terminals.
    von Euler US
    Adv Cytopharmacol; 1971 May; 1():363-7. PubMed ID: 4148190
    [No Abstract]   [Full Text] [Related]  

  • 10. Antagonism by (+)-amphetamine of the inhibition of [3H]-noradrenaline overflow obtained by alpha-adrenoceptor agonists or bretylium in the perfused cat spleen [proceedings].
    Dubocovich ML; Langer SZ; Moret C
    Br J Pharmacol; 1979 Jul; 66(3):460P-461P. PubMed ID: 43177
    [No Abstract]   [Full Text] [Related]  

  • 11. On the mechanism of the adrenergic nerve blocking action of bretylium.
    Haeusler G; Haefely W; Huerlimann A
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(3):260-77. PubMed ID: 4243221
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the mechanism of the adrenergic blocking action of bretylium and guanethidine].
    Haeusler G; Haefely W; Huerlimann A
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):241-3. PubMed ID: 4242393
    [No Abstract]   [Full Text] [Related]  

  • 13. The action of acetyl choline and other drugs upon the terminal parts of the postganglionic sympathetic fibre.
    Cabrera R; Torrance RW; Viveros H
    Br J Pharmacol Chemother; 1966 May; 27(1):51-63. PubMed ID: 5961470
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective depletion of noradrenaline: a proposed mechanism of the adrenergic neurone-blocking action of bretylium.
    Abbs ET; Robertson MI
    Br J Pharmacol; 1970 Apr; 38(4):776-91. PubMed ID: 5441790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the possibility of chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine (6-OH-DA)].
    Thoenen H; Tranzer JP
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):212-3. PubMed ID: 4239240
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of bretylium on the subcellular distribution of noradrenaline and on adrenergic nerve function in rat heart.
    Abbs ET; Pycock CJ
    Br J Pharmacol; 1973 Sep; 49(1):11-22. PubMed ID: 4787519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholine, bretylium and release of norepinephrine from sympathetic nerve endings.
    Kopin IJ
    Ann N Y Acad Sci; 1967 Oct; 144(2):558-62. PubMed ID: 4295406
    [No Abstract]   [Full Text] [Related]  

  • 18. Delay by bretylium of adrenergic nerve degeneration after sympathectomy of the submaxillary gland.
    Arbilla S; Perec CJ; Stefano FJ
    Eur J Pharmacol; 1980 Jan; 61(2):147-57. PubMed ID: 7353586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of drugs on the 6-hydroxydopamine induced degeneration of adrenergic nerves.
    Jonsson G; Malmfors T; Sachs C
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):543-56. PubMed ID: 5034513
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of bretylium on C fibre excitation and noradrenaline release by acetylcholine and electrical stimulation.
    Davey MJ; Hayden ML; Scholfield PC
    Br J Pharmacol; 1968 Oct; 34(2):377-87. PubMed ID: 5687592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.